Risk factors for mortality in patients with nosocomial Stenotrophomonas maltophilia pneumonia
- PMID: 19852664
- DOI: 10.1086/648455
Risk factors for mortality in patients with nosocomial Stenotrophomonas maltophilia pneumonia
Abstract
Objective: The aim of this study was to determine potential risk factors for mortality in patients with nosocomial Stenotrophomonas maltophilia pneumonia.
Design: A retrospective, single-center, observational study.
Setting: A 2400-bed tertiary teaching hospital in southern Taiwan.
Patients and methods: This retrospective study evaluated patients (age, at least 18 years) with nosocomial pneumonia (S. maltophilia isolated from respiratory culture) who were seen at Kaohsiung Chang Gung Memorial Hospital over a 3-year period. A total of 406 patients (64% male, mean age +/- standard deviation, 69.6 +/- 14.93 years; mean duration of hospital +/- standard deviation, 57.5 +/- 39.47 days) were included.
Results: Most index isolates (53.9%) were from the first sample cultured. Polymicrobial isolates were cultured from samples from 177 (43.6%) of the 406 study patients. The most common copathogen was Pseudomonas aeruginosa (53.11% of isolates). The all-cause hospital mortality rate was 42.6% (173 deaths among 406 patients). Survivors had a shorter time from admission to a positive index culture result than did nonsurvivors (26.1 vs 31.7 days; P = .04). Mortality was significantly higher among patients with malignancy (adjusted odds ratio [AOR], 2.48; 95% confidence interval [CI], 1.52-4.07; P < .001), renal disease (AOR, 2.6; 95% CI, 1.51-4.47; P = .001), intensive care unit stay (AOR, 1.72; 95% CI, 1.1-2.7; P = .018), and inadequate initial empirical antibiotic therapy (AOR, 2.17; 95% CI, 1.4-3.38; P = .001).
Conclusions: S. maltophilia pneumonia is associated with a high mortality rate and is commonly associated with concomitant polymicrobial colonization or infection. Underlying comorbidities and inadequate initial empirical antibiotic therapy substantially account for increased mortality rates.
Similar articles
-
Clinical importance of Stenotrophomonas maltophilia nosocomial pneumonia due to its high mortality in hemodialysis patients.Ther Apher Dial. 2009 Jun;13(3):193-8. doi: 10.1111/j.1744-9987.2009.00693.x. Ther Apher Dial. 2009. PMID: 19527465
-
Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study.Crit Care. 2019 Nov 21;23(1):371. doi: 10.1186/s13054-019-2649-5. Crit Care. 2019. PMID: 31752976 Free PMC article.
-
Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004.Eur J Clin Microbiol Infect Dis. 2007 Jan;26(1):13-20. doi: 10.1007/s10096-006-0243-7. Eur J Clin Microbiol Infect Dis. 2007. PMID: 17200840
-
Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases.Ann Hematol. 2014 Jun;93(6):901-11. doi: 10.1007/s00277-014-2028-x. Epub 2014 Feb 18. Ann Hematol. 2014. PMID: 24535696 Review.
-
Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review.J Hosp Infect. 2008 Oct;70(2):101-8. doi: 10.1016/j.jhin.2008.05.020. Epub 2008 Jul 14. J Hosp Infect. 2008. PMID: 18621440 Review.
Cited by
-
An Assessment of Human Opportunistic Pathogenic Bacteria on Daily Necessities in Nanjing City during Plum Rain Season.Microorganisms. 2024 Jan 26;12(2):260. doi: 10.3390/microorganisms12020260. Microorganisms. 2024. PMID: 38399664 Free PMC article.
-
Stenotrophomonas maltophilia Infections in Haematological Malignancies and Hematopoietic Stem Cell Transplantation: A Case Series including Cefiderocol-Based Regimens.Medicina (Kaunas). 2024 Jan 3;60(1):88. doi: 10.3390/medicina60010088. Medicina (Kaunas). 2024. PMID: 38256349 Free PMC article.
-
Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014-2021.Microbiol Spectr. 2023 Dec 12;11(6):e0198123. doi: 10.1128/spectrum.01981-23. Epub 2023 Nov 3. Microbiol Spectr. 2023. PMID: 37921464 Free PMC article.
-
Stenotrophomonas maltophilia Periprosthetic Joint Infection after Hip Revision Arthroplasty.Hip Pelvis. 2023 Jun;35(2):142-146. doi: 10.5371/hp.2023.35.2.142. Epub 2023 Jun 2. Hip Pelvis. 2023. PMID: 37323547 Free PMC article.
-
Stenotrophomonas maltophilia pneumonia in critical COVID-19 patients.Sci Rep. 2023 Feb 28;13(1):3392. doi: 10.1038/s41598-023-28438-x. Sci Rep. 2023. PMID: 36854720 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
